Skip to main content

Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma

  • Chapter
Transplantation in Hematology and Oncology

Abstract

Over the past few years the outcome of patients with high grade osteosarcoma (OST) improved dramatically, with survival rates rising from 15% up to 70% [1]. The relatively large series of subjects reported by the Rizzoli Institute and Scandinavian Sarcoma Group confirm that the results of treatment improve with increasing aggressiveness of the chemotherapy, showing a dose-response relationship regarding tumor response and survival [2,3]. By contrast, patients with overt metastatic disease at diagnosis as well as those with disease recurrence have a poor prognosis [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Li MP, Eilber F. Osteosarcoma. In: Pizzo PA and Poplack DG (eds.). Principle and practice of pediatric oncology. Lippincott-Raven: Philadelphia 1997, pp 889–920

    Google Scholar 

  2. Bacci G, Picci P, Avella M et al. The importance of dose intensity in neoadjiuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adrya-micin used preoperatively. J Chemother 1990; 2:127–135

    PubMed  CAS  Google Scholar 

  3. Saeter G. Treatment strategies outcome in metastatic (relapsed) osteogenic sarcoma. The Scandinavian Sarcoma Group (SSG) experience. Med Ped Oncol 1996; 27: 264(abstr. 212)

    Google Scholar 

  4. Sanders JE. Bone marrow transplantation in pediatric oncology. In: Pizzo PA and Poplack DG (eds.). Principle and practice of pediatric oncology. Lippincott-Raven: Philadelphia 1997, pp 357–373

    Google Scholar 

  5. Valteau-Couanet D, Kalifa C, Benhamou E et al. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation support in children with metastatic osteosarcoma. Med Ped Oncol 1996; 27: 239 (abstr.111)

    Google Scholar 

  6. Williams TE, Safarimaryaky S. Bone marrow transplantation for treatment of solid tumors. In: Johnson FL and Pochedly C (eds.). Bone marrow transplantation in children. Raven Press: New York, 1990, pp 221–242

    Google Scholar 

  7. Pession A, Thienghi A, Rosito P et al. Peripheral blood stem cell transplantation (PBSCT) in high risk Ewing sarcoma. Med Ped Oncol 1996; 27: 238 (abstr. 108)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Miniero, R. et al. (2000). Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma. In: Berdel, W.E., et al. Transplantation in Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59592-9_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59592-9_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64041-4

  • Online ISBN: 978-3-642-59592-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics